Jupiter Topco’s Palisade Bio PALI Stock Holding History

Jupiter Topco’s Portfolio PALI Stock Details PALI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.4M	Buy	+10,689,452	New	+$21M	0.01%	630

Other funds holding PALI

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BGI

B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Jupiter Topco's PALI Position: Q2 2026 in Review

Jupiter Topco opened a new position in Palisade Bio (PALI) in Q2 2026: 10,689,452 shares worth $22.4M. The stake represents 0.01% of the portfolio and ranks #630 among its holdings.

113 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

Jupiter Topco held 10,689,452 shares of Palisade Bio worth $22.4M as of Q2 2026.
Palisade Bio was a new Jupiter Topco position in Q2 2026.
Palisade Bio made up 0.01% of Jupiter Topco's portfolio in Q2 2026, its #630 holding.
113 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.